Flubromazolam isn't known to obtain any therapeutic use, is not to the WHO Design Listing of Necessary Medicines and has never been promoted like a medicinal item. The metabolism of flubromazolam is hepatic which is no less than partially mediated from the CYP3A4/five and UGT1A4 enzymes [